We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Information for patients, public and health care professionals.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
Training and continuing professional development (CPD) for people working in the NHS breast screening programme (BSP) in England.
This advice has been written by the Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG) at the request of the Medicines and Healthcare products Regulatory Agency (MHRA – UK regulator). It is in the form of questions, asked of...
This guidance explains what the Sloane Project is and how breast screening units (BSUs) can submit data.
Population screening programmes: NHS breast screening (BSP) programme. The pages tagged as BSP will appear here.
Read an overview of the NHS breast screening programme (BSP), and learn how to contact the programme.
Information for clinicians and patients.
Guidelines for generating consistent pathological data from breast screening services.
RIDA funds research and development in new technologies, and new approaches to existing technologies, that support Sustainable Development Goals in south-east Asia.
Standards and guidance for health professionals, managers and commissioners working in the NHS breast screening programme.
NHS Breast Screening Programme position statement on reporting of breast density
Procedures to ensure the interval between breast screening and invitation for the next screen is 36 months for all eligible women.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).